Presenting Company Session:
Gene Predictis SA
Gene Predictis is a pioneering Swiss company at the forefront of precision medicine. We develop disruptive predictive and diagnostics technologies answering major medical needs and delivered them through our state-of-the-art authorized testing laboratories in Switzerland or through partnerships with other companies.
Our strengths are:
• unique expertise in developing polygenic and multifactorial risk scores and algorithms for interpreting complex genetic data, as demonstrated through already developed and recognized products
• broad and proven know-how covering all aspects of IVD life cycle (including product development, clinical validation, patenting, regulatory approvals, CE-IVD marking and reimbursement)
• unique and differentiated portfolio in pharmacogenetics and nutrigenetics with products recognized as highly innovative, clinically useful and that have significant market potential; first of the kind to be reimbursed in Switzerland and Europe
• extensive catalogue with over 80 clinically relevant genetic tests including onco-pharmacogenetic tests and oncogenetic tests
• strong productivity based on a solid laboratory infrastructure managed by a qualified team.
We are currently reinforcing our business development strategy to assure fast growth over the next three years leveraging on our 3 scientific pillars: offer of lifestyle genetic tests, as well as on pharmacogenetics and oncogenetic testing.
We are the Swiss epigenetic company estimating the environmental and lifestyle impacts on biological age, a new measure of premature aging and overall health.
Genknowme has been founded in 2019 by a team of passionate scientists. This innovative life sciences company dedicates itself to the transformation of cutting-edge research into epigenetic signatures that measure the impact of lifestyle on biological age. We provide a next-generation-genetics blood tests to support healthcare professionals while they coach their patients into making healthy lifestyle changes.
Everything we do is about self-knowledge. We believe that knowing oneself is a priority, and we demonstrate this by revealing the most intimate knowledge there is, an epigenetic profile explaining how your genes interact with your environment.
Metadvice AI distills complex disease treatment and outcome data into actionable insights for clinicians and patients, assisting pharmaceutical companies with real world evidence. The clinical knowledge engine sources data from a network of practitioners to take precision medicine to the next level!
Novigenix is a Swiss precision oncology company specialised in ImmunoTranscriptomic solutions for the detection of disease and therapy optimisation to support disease management.
The proprietary platform of the company LITOseek is optimised for mapping the response of the immune system to onset and progression of disease by integrating patient data, advanced Machine Learning, and Artificial Intelligence approaches that provide actionable insights and precision solutions for optimisation of patient’s therapeutic journey. The company product pipeline includes patient stratification solutions in Immuno-Oncology, Colorectal Cancer early detection and recurrence monitoring, and other therapy optimisation solutions for management of patients.